112 related articles for article (PubMed ID: 9614005)
1. Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors.
Veal GJ; Agrawal S; Byrn RA
Antiviral Res; 1998 Apr; 38(1):63-73. PubMed ID: 9614005
[TBL] [Abstract][Full Text] [Related]
2. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.
Yamaguchi K; Papp B; Zhang D; Ali AN; Agrawal S; Byrn RA
AIDS Res Hum Retroviruses; 1997 May; 13(7):545-54. PubMed ID: 9135872
[TBL] [Abstract][Full Text] [Related]
3. A new class of anti-HIV-1 oligonucleotide targeted to the polypurine tract of viral RNA.
Hiratou T; Miyano-Kurosaki N; Gushima H; Takaku H
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):715-8. PubMed ID: 11563099
[TBL] [Abstract][Full Text] [Related]
4. Oligonucleotides as inhibitors of human immunodeficiency virus.
Field AK
Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
[TBL] [Abstract][Full Text] [Related]
5. Three-drug combinations of emivirine and nucleoside reverse transcriptase inhibitors in vitro: long-term culture of HIV-1-infected cells and breakthrough viruses.
Nitanda T; Wang X; Somekawa K; Yuasa S; Baba M
Antivir Chem Chemother; 2001 May; 12(3):161-7. PubMed ID: 12959324
[TBL] [Abstract][Full Text] [Related]
6. Anti-human immunodeficiency virus type 1 (HIV-1) activity of 2'-fluoro-2',3'-dideoxyarabinosyladenine (F-ddA) used in combination with other mechanistically diverse inhibitors of HIV-1 replication.
Buckheit RW; Russell JD; Pallansch LA; Driscoll JS
Antivir Chem Chemother; 1999 May; 10(3):115-9. PubMed ID: 10431610
[TBL] [Abstract][Full Text] [Related]
7. Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro.
Hoggard PG; Sales SD; Kewn S; Sunderland D; Khoo SH; Hart CA; Back DJ
Antivir Chem Chemother; 2000 Nov; 11(6):353-8. PubMed ID: 11227992
[TBL] [Abstract][Full Text] [Related]
8. Anti-human immunodeficiency virus type 1 of a two-strand-system targeted to the polypurine tract.
Hiratou T; Miyano-Kurosaki N; Tsukahara S; Tamura Y; Takai K; Yamamoto N; Takaku H
Int J Mol Med; 2000 Feb; 5(2):125-32. PubMed ID: 10639589
[TBL] [Abstract][Full Text] [Related]
9. Sequence-specific RNase H cleavage of gag mRNA from HIV-1 infected cells by an antisense oligonucleotide in vitro.
Veal GJ; Agrawal S; Byrn RA
Nucleic Acids Res; 1998 Dec; 26(24):5670-5. PubMed ID: 9837998
[TBL] [Abstract][Full Text] [Related]
10. GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS.
Agrawal S; Tang JY
Antisense Res Dev; 1992; 2(4):261-6. PubMed ID: 1363378
[No Abstract] [Full Text] [Related]
11. Long-term exposure of HIV type 1-infected cell cultures to combinations of the novel quinoxaline GW420867X with lamivudine, abacavir, and a variety of nonnucleoside reverse transcriptase inhibitors.
Balzarini J; De Clercq E; Carbonez A; Burt V; Kleim JP
AIDS Res Hum Retroviruses; 2000 Apr; 16(6):517-28. PubMed ID: 10777142
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells.
Lisziewicz J; Sun D; Weichold FF; Thierry AR; Lusso P; Tang J; Gallo RC; Agrawal S
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7942-6. PubMed ID: 8058738
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted to the polypurine tract.
Hiratou T; Tsukahara S; Miyano-Kurosaki N; Takai K; Yamamoto N; Takaku H
FEBS Lett; 1999 Jul; 456(1):186-90. PubMed ID: 10452555
[TBL] [Abstract][Full Text] [Related]
15. Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors.
Sugiura W; Matsuda M; Matsuda Z; Abumi H; Okano A; Oishi T; Moriya K; Yamamoto Y; Fukutake K; Mimaya J; Ajisawa A; Taki M; Yamada K; Nagai Y
J Hum Virol; 1999; 2(3):146-53. PubMed ID: 10413366
[TBL] [Abstract][Full Text] [Related]
16. Oxandrolone, used for treatment of wasting disease in HIV-1-infected patients, does not diminish the antiviral activity of deoxynucleoside analogues in lymphocyte and macrophage cell cultures.
Segal DM; Perez M; Shapshak P
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):215-9. PubMed ID: 10077168
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
18. Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5'-triphosphates of various anti-HIV nucleoside analogs.
White EL; Parker WB; Ross LJ; Shannon WM
Antiviral Res; 1993 Dec; 22(4):295-308. PubMed ID: 7506513
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H
Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes.
Aquaro S; Perno CF; Balestra E; Balzarini J; Cenci A; Francesconi M; Panti S; Serra F; Villani N; Caliò R
J Leukoc Biol; 1997 Jul; 62(1):138-43. PubMed ID: 9226005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
